La identificacin de la DPP4 como la enzima responsable de la vida media corta de las incretinas llev a plantear que la inhibicin de su accin, podra tener un rol en la terapia de la DM2, al aumentar los niveles de GLP1 y prolongar su accin insulinotrpica47
This means that, overall, tirzepatide is a more effective medication, but can cause more severe side effects, possibly to it being more potent due to its dual-action mechanism
This is great news for people with Type 2 diabetes
The most important distinction: Zepbound is a weight-management medication
Interestingly, new research published in the journal Nature Medicine evaluated the health outcomes of more than 2 million veterans with diabetes taking a GLP-1 and found that while the medications had positive effects on several health conditions, like heart disease and substance use disorders, they were negatively associated with some, including arthritis